Roche’s subcutaneous OCREVUS one-year data demonstrates near-complete suppression of clinical relapses and brain lesions in patients with progressive and relapsing forms of MS

5h ago

PremiumThe Fly

Fresenius SE launches biosimilar of Roche’s Actemra

2d ago

PremiumThe Fly

Genentech announces STARGLO study meets primary endpoint

2d ago

$[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in Phase III STARGLO study$

PremiumPress Releases

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in Phase III STARGLO study

2d ago

PremiumThe Fly

Roche announces U.S. FDA granted BDD to its Elecsys pTau217 assay

6d ago

LLY

PremiumPress Releases

Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer’s disease diagnosis

6d ago

PremiumThe Fly

Roche announces CE Mark for Ventana HER2 Rabbit Monoclonal Primary RxDx

7d ago

AZN

More RHHVF News >

RHHVF News on the Web

2024-04-15

Genentech’s Columvi Meets Primary Endpoint of Overall Survival in People With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Phase III STARGLO Study

Yahoo Finance

Neutral

2024-04-15

Roche’s Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in Phase III STARGLO study

Yahoo Finance

Neutral

2024-04-11

Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis

Yahoo Finance

Neutral

2024-04-10

Roche obtains CE Mark for first companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for ENHERTU

Yahoo Finance

Neutral

2024-04-08

Barclays Sticks to Their Hold Rating for Roche Holding AG (RHHVF)

TipRanks News

Neutral

2024-04-02

J.P. Morgan Reaffirms Their Sell Rating on Roche Holding AG (RHHVF)

TipRanks News

Bearish

2024-03-26

Roche receives FDA approval for the first molecular test to screen for malaria in blood donors

Yahoo Finance

Neutral

2024-03-12

Roche Annual General Meeting 2024

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

RHHVF

Sector Average

Media Buzz

This Week4 articles

Weekly Average1.75 articles

News Sentiment

This Week50%

Sector Average65%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RHHVF’s Media Buzz Sentiment?

4 articles about RHHVF were published this week. In an average week, 1.75 articles are published.

What is RHHVF’s weekly average amount of articles?

In an average week, 1.75 articles about RHHVF are published.

What is RHHVF’s News Sentiment?

50% of articles about RHHVF were positive this week, compared to its sector average of 65%.

Healthcare Stocks that are Trending in the News

0HNZFagron SA

ALPNAlpine Immune Sciences

JANXJanux Therapeutics Inc

SIGASIGA Technologies

INNMFAmplia Therapeutics Ltd.

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing